A group of international researchers has developed a point-of-care device that may produce a consistent and cost-effective screening method for thyroid nodules.

A group of Chinese scientists and clinicians developed a learning artificial intelligence (AI) platform able to diagnose prostate cancer with the same accuracy as a human pathologist, according to a European Association of Urology press release.

A new portable brain imaging system developed at the University of Calgary in Canada uses infrared light sensors and computational assistance to determine the extent of damage and long-term consequences of concussions, according to a recent university news release.

Robert Pearl, MD, from Stanford University shared his thoughts about the gradual permeation of artificial intelligence (AI) into the culture and business of medicine in a recent editorial in Forbes. 

Royal Philips, a global leader in health technology, today announced Massachusetts General Hospital (MGH) and Brigham and Women's Hospital (BWH), both members of the Partners HealthCare network, will implement the Philips IntelliSite Pathology Solution to enable research and support clinical diagnosis.

The Association for Medical Imaging Management (AHRA) recently announced a new campaign to reach 6,000 members, according to an association press release.

A Pennsylvania woman was shocked when quoted $351 for a breast MRI from the Crozer-Keystone Health System, before being billed $4,650 for the exam.  

The legislation would have let nurse practitioners, certified registered nurse anesthetists and clinical nurse specialists perform and supervise medical imaging procedures, according to the American Society of Radiologic Technologists (ASRT).

Washington University in St. Louis is set to become the second institution with a doctoral program dedicated to imaging science, with its inaugural class beginning in the fall. Mark Anastasio, PhD, the director of the new program, spoke with Health Imaging about the state of imaging education and incorporating artificial intelligence (AI) into its curriculum.

Co-founders of NIRAMAI, an artificial intelligence (AI) imaging tech startup, Geetha Manjunatha, CEO, and Nidhi Mathur, COO, developed non-invasive methods for breast cancer screening, according to a recent article published by Analytics India Magazine.